Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from JCR Pharmaceuticals Co., Ltd. ( (JP:4552) ).
JCR Pharmaceuticals Co., Ltd. announced a plan to dispose of 111,000 shares of its treasury stock as part of a restricted stock compensation plan aimed at incentivizing its directors and employees. This initiative is designed to align the interests of the company’s leadership with those of its shareholders, promoting sustained corporate value enhancement and ensuring continued commitment from key personnel.
The most recent analyst rating on (JP:4552) stock is a Hold with a Yen590.00 price target. To see the full list of analyst forecasts on JCR Pharmaceuticals Co., Ltd. stock, see the JP:4552 Stock Forecast page.
More about JCR Pharmaceuticals Co., Ltd.
JCR Pharmaceuticals Co., Ltd. is a Japanese company operating in the pharmaceutical industry, focusing on the development and commercialization of biopharmaceuticals. The company is known for its innovative treatments and therapies, particularly in the area of rare diseases, and aims to enhance corporate value through strategic initiatives.
Average Trading Volume: 1,129,338
Technical Sentiment Signal: Sell
Current Market Cap: Yen64.72B
For a thorough assessment of 4552 stock, go to TipRanks’ Stock Analysis page.